Loretta Swit, Emmy-winning actress and star of M*A*S*H, dies aged 87
Loretta Swit, who won Emmy Awards for her role on the comedy series M*A*S*H, has died aged 87.
Her publicist, Harlan Boll, said the actress passed away at her home in New York City just after midday on Friday, likely from natural causes.
She was best known for her star turn as Major Margaret Houlihan on CBS' M*A*S*H, which aired for 11 years from 1972 to 1983.
Based on Robert Altman's 1970 film of the same name, M*A*S*H has been ranked as one of the greatest shows of all time by Rolling Stone and Time Out, with the finale watched by more than 100 million viewers - the most-watched episode of any scripted series ever.
In the film, Major Margaret Houlihan was a one-dimensional, promiscuous character nicknamed Hot Lips, but the character was developed and deepened in the show.
Swit told Suzy Kalter, author of "The Complete Book of M*A*S*H," that as the show went on, "I decided to try to play her as a real person, in an intelligent fashion, even if it meant hurting the jokes".
She won Emmy Awards for Outstanding Supporting Actress in a Comedy Series in 1980 and 1982 for her role in the show.
Born Loretta Jane Szwed in Passaic, New Jersey, in 1937, she was the daughter of Polish immigrants.
She enrolled in the American Academy of Dramatic Arts before arriving in Hollywood in 1969.
Along with M*A*S*H, she made appearances in shows like Gunsmoke, Hawaii Five-O, Mission Impossible and Bonanza.
Swit also made regular appearances in theatre, starring on Broadway in 1975 in Same Time, Next Year, and The Mystery of Edwin Drood in 1986.
Swit also appeared in a number of TV musical specials, including The Muppet Show and the Broadway musical It's a Bird, It's a Plane, It's Superman.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
Doritos and Skittles could carry ‘not recommended for human consumption' warning labels in certain parts of the US
Some of America's favorite snacks may be banned in certain parts of the U.S. if the packaging does not warn about certain ingredients. New legislation in Texas would warn consumers in the state about ingredients that are 'not recommended for human consumption' in other countries, but still allowed in the U.S., Bloomberg reported. More than 40 ingredients, from synthetic food dyes to bleached flour, would require warning labels on the products' packaging starting in 2027, if the bill is signed into law. The legislation would affect snacks and candies such as Nacho Cheese Doritos, Little Bites Chocolate Chip Muffins, Skittles, M&Ms and Sour Patch Kids Watermelon, as well as breakfast cereals and sodas such as Froot Loops, Cinnamon Toast Crunch and Mountain Dew. If the bill is signed by Governor Greg Abbott, it would affect snacks sold statewide. This could also open the door for a nationwide switch-up. Bloomberg reported that companies forced to comply with state regulations often chose to roll out changes across the whole country to streamline production. Abbott has less than 20 days to sign the bill, and it's unclear whether he will. His press secretary, Andrew Mahaleris, told Bloomberg before the bill was sent to the governor: 'Abbott will continue to work with the legislature to ensure Texans have access to healthy foods to care for themselves and their families and will thoughtfully review any legislation they send to his desk.' If the bill is signed into law, there are instances when the state-mandated labeling won't be required: if the Food and Drug Administration or Department of Agriculture deems an ingredient safe, restricts its use or bans it after September 1. Industry groups and companies, including food and drink makers and retail giant Walmart, had sent a letter to Texas lawmakers 'in strong opposition' to the bill. 'As it's written, the food labeling provision in this bill casts an incredibly wide net — triggering warning labels on everyday grocery items based on assertions that foreign governments have banned such items, rather than on standards established by Texas regulators or by the U.S. Food and Drug Administration,' read the letter, which had circulated on social media. The letter warned that this potential change 'could destabilize local and regional economies at a time when businesses are already fighting to keep prices down, maintain inventory, and avoid layoffs.' If the bill did get signed into law, it would be a win for not only Texas lawmakers but Health and Human Services Secretary Robert F. Kennedy Jr., a vocal critic of certain chemicals in food like synthetic dyes. Supporters of the Texas bill have claimed that Kennedy backs the legislation, Bloomberg reported. According to the outlet, Texas Representative Lacey Hull claimed she received a call from the HHS secretary when it passed.
Yahoo
22 minutes ago
- Yahoo
🎥 Lukas Podolski turns 40: four rockets for his birthday cake
The Kölsche Jung is having a birthday. Of course, we want to remember his left foot, with which Lukas Podolski conjured up many beautiful goals throughout his career. DFB fans will probably remember his goal from the farewell match against England. Poldi also showed what he can do with his feet at 1. FC Köln. And because Arsenal was also mentioned by the Kölners, a rocket like this one must not be missing. But the striker still hasn't had enough of football and recently extended his contract with Gornik Zabrze. In the Polish first division, Poldi shows that he can still score beautiful goals at his age. Advertisement We can't get enough of Podolski's left foot. We wish him all the best on his 40th birthday and look forward to more dream goals from Poland. This article was translated into English by Artificial Intelligence. You can read the original version in 🇩🇪 here. 📸 Lars Baron -
CNBC
23 minutes ago
- CNBC
Health care stocks are due for a turnaround after a historically bad month, according to the charts
The Health Care Select Sector SPDR Fund (XLV) was down over 5% in May, as the S & P 500 gained over 6%, which means that XLV underperformed the index by 11%. That's a huge performance discrepancy. In fact, it was the worst relative monthly percent move vs. the SPX in XLV's history, dating back to late 1998. As is clear from this long-term chart, the odds of this horribly bad relative weakness continuing at this same pace is low – at least for June. XLV itself now has approached two major long-term support levels after the recent downturn. The first is the rising trendline that begins at the 2009 financial crisis low and extends through the Covid bottom. XLV tested this line in mid-May, bounced and finished the month modestly off its lows. The second key support zone comes from the cluster of lows in 2021, 2022 and 2023, noted by the horizontal line that's in the low 120s. The converging lines present a confluence of support that clearly could help XLV's bouncing prospects in June. XLV: The 3 biggest holdings Believe it or not, 34 of XLV's 61 components actually logged gains in May. That's encouraging, but we'll need to see its biggest holdings respond soon. If they can't rally, XLV will continue to struggle. The three largest stocks within the ETF are Eli Lilly , Johnson & Johnson and AbbVie , which make up nearly 27% of XLV combined. So, what are the odds that all three stocks actually can mount strong up-moves in June? Let's take a closer look. We'll start with LLY since it's XLV's biggest component, with a 12% weighting. LLY last made an all-time high in August 2024. From that peak to its April low, the stock lost 30%. But as the following weekly chart (in log scale) shows, it wasn't straight down from there. LLY logged various rallies and drawdowns since then, all of which have taken place within the pictured downward sloping trading channel. The best time to buy LLY, thus, has been after a big, long decline. The stock just fell another 20% from April 30 through May 25. As we can see, the past ensuing bounces yielded big percentage moves, even if they ultimately failed to break through the channel's upper threshold. Additionally, LLY's weekly Williams %R indicator (on the lower panel) is emerging from an oversold condition, which has supported three of the last four big up-moves. In fact, LLY quietly has logged gains in six of the last seven trading days. That's a good start. JNJ (7.7% weight) has been trending lower since topping in 2022, while ABBV (6.8%) has been in a clear uptrend the last few years. However, both have experienced various swings within their respective long-term trading channels — like LLY. And with both JNJ and ABBV having sold off from their 2025 highs, now would be an opportune time for the next bounce to commence. From a big picture market perspective, rotation is an important component of true, long-lasting uptrends. Thus, if/when the air comes out of the more extended sectors and groups soon, capital could find its way to the underperforming areas, which of course, includes health care. DISCLOSURES: None. All opinions expressed by the CNBC Pro contributors are solely their opinions and do not reflect the opinions of CNBC, NBC UNIVERSAL, their parent company or affiliates, and may have been previously disseminated by them on television, radio, internet or another medium. THE ABOVE CONTENT IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY . THIS CONTENT IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSITUTE FINANCIAL, INVESTMENT, TAX OR LEGAL ADVICE OR A RECOMMENDATION TO BUY ANY SECURITY OR OTHER FINANCIAL ASSET. THE CONTENT IS GENERAL IN NATURE AND DOES NOT REFLECT ANY INDIVIDUAL'S UNIQUE PERSONAL CIRCUMSTANCES. THE ABOVE CONTENT MIGHT NOT BE SUITABLE FOR YOUR PARTICULAR CIRCUMSTANCES. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR. Click here for the full disclaimer.
